Scientists from UK firm Amersham Biosciences and the University ofDelaware in the USA have succeeded in conducting the first-ever DNA sequencing experiments to be carried out while at sea.
Using the research vessel Atlantis and submersible Alvin, the team is carrying out an environmental genomic study of the organisms that inhabit super-hot hydrothermal vents almost two miles deep in the Pacific Ocean. By the end of the 17-day research cruise, the scientists estimate that they will sequence just under two million base pairs of DNA from different microbes and organisms that live in and around the vents.
The amount of DNA sequenced during the trip will be equivalent to the size of a small bacterial genome, which typically range from two million to five million base pairs, according to Amersham. The microbes, tubeworms and other vent dwellers are of interest to industry because these organisms may yield a range of new products and applications, from new pharmaceuticals to heat-stable, pressure-resistant enzymes for food processing, hazardous waste cleanup and other fields.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze